Key result
IVIG yields complete recovery and viral clearance in neonatal enterovirus sepsis.
Why the study?
Does intravenous immunoglobulin improve outcomes in a newborn with enterovirus sepsis?
Case Report (n=1)
No
Does intravenous immunoglobulin improve outcomes in a newborn with enterovirus sepsis?
Intravenous immunoglobulin may be an effective, life-saving treatment for neonatal enterovirus sepsis.
Answers are grounded in this paper and cite their sources.
May support IVIG in neonatal enterovirus sepsis; leaves open confirmation in prospective trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hafeez et al. (2018) conducted a case report in Neonatal enterovirus sepsis (n=1). Intravenous immunoglobulin (IVIG) was evaluated on Clinical recovery and viral clearance (negative EV RNA PCR). Treatment with intravenous immunoglobulin (500 mg/kg/day for 4 days) led to complete clinical recovery and viral clearance in a neonate with enterovirus sepsis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: